High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies
Journal of Atherosclerosis and Thrombosis · 01.01.2026 · 33 (1) · 1-12
DOI: 10.5551/jat.rv22044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.01.2026. Verfasst von Masahiro Katamine und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Kitasato University School of Medicine. Hauptthemen laut MEDLINE: C-Reactive Protein, Coronary Artery Disease, Inflammation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Inflammation plays a crucial role in the initiation, progression, and destabilization of atherosclerotic plaques and it contributes to recurrent cardiovascular events in patients with coronary artery disease (CAD). High-sensitivity C-reactive protein (hsCRP) is a well-established biomarker of systemic inflammation and it is a predictor of adverse outcomes, independent of low-density lipoprotein cholesterol (LDL-C) levels. Elevated hsCRP levels are consistently associated with higher event rates in both chronic and acute coronary syndromes, thus reflecting the residual inflammatory risk not addressed by lipid-lowering therapy or revascularization. Imaging studies have revealed that higher hsCRP levels correlate with a greater plaque burden and vulnerability. Recent trials have shown that anti-inflammatory therapies, including low-dose colchicine and interleukin-6 inhibition, can reduce this residual risk, while agents such as glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, and bempedoic acid offer additional anti-inflammatory effects. The integration of anti-inflammatory strategies with intensive lipid management may thus provide additional cardiovascular benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Kitasato University School of Medicine.
Zitieren
APA
Katamine, M., Minami, Y., & Ako, J. (2026). High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies. Journal of Atherosclerosis and Thrombosis, 33(1), 1-12. https://doi.org/10.5551/jat.rv22044
Vancouver
Katamine M, Minami Y, Ako J. High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies. Journal of Atherosclerosis and Thrombosis. 2026;33(1):1-12. doi:10.5551/jat.rv22044
BibTeX
@article{Katamine2026,
author = {Katamine, Masahiro and Minami, Yoshiyasu and Ako, Junya},
title = {High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2026},
volume = {33},
number = {1},
pages = {1--12},
doi = {10.5551/jat.rv22044}
}
EUVIMED